GIC Pharma Feed
The latest developments, from trade analysis to corporate breakthroughs in the pharmaceutical industry.
Industry Insights & Association News
Content from trade magazines, professional associations, and expert commentary related to the Digital Pharma Conference.
Trade & Professional Publications
Source: PharmacyBiz | 7 November 2025
US Diplomat urges UK government to address NHS drug pricing policies, citing risk of pharmaceutical investment flight and R&D reduction from the United Kingdom.
Source: PharmacyBiz
Source: The Guardian | 30 October 2025
Frontline reports detail how UK pharmaceutical pricing disputes negatively impact clinical trial progress, industry employment, and crucial patient access to innovative therapies.
Source: The Guardian
Source: PM360 | 28 October 2025
Following high-level US negotiations, the United Kingdom is preparing to allocate increased budget for pharmaceutical procurement, anticipating inevitable drug cost rises.
Source: PM360
Association Updates
Source: ABPI | 6 November 2025
The ABPI 2025 Industry Summit emphasizes pharmaceutical sector commitments to enhanced public trust, market transparency, and accelerated innovation pathways for patient benefit.
Source: ABPI
Source: HaDEA (European Commission) | 6 November 2025
EU4Health Joint Actions focus on strengthening pan-European pharmacovigilance, ensuring regulatory compliance, and guaranteeing the quality and safety of medical products.
Source: HaDEA (European Commission)
Source: BioIndustry Association (BIA) | 1–7 November 2025
The BioIndustry Association (BIA) provides an update on recent UK Life Sciences funding allocations, government policy changes, and crucial sector priorities for growth and investment.
Source: BioIndustry Association (BIA)
Market Analysis & Commentary
Source: Financial Times | 6 November 2025
AstraZeneca CEO warns that European states under-paying for prescription drugs endangers the continent's 'health sovereignty' and global pharmaceutical competitiveness.
Source: Financial Times
Source: Pharmaphorum | 6 November 2025
UK Hospital Episode Statistics (HES) provide powerful, actionable real-world evidence (RWE) critical for optimizing pharmaceutical market access strategies and patient care pathways.
Source: Pharmaphorum
Source: PharmacyBiz | 7 November 2025
Detailed macro-economic analysis reveals the escalating strain on the UK pharmaceutical industry due to intense NHS spending pressures and ongoing pricing conflicts.
Source: PharmacyBiz
Regulatory & Compliance Watch
Source: RAPS | 4 November 2025
The MHRA is committed to a major regulatory overhaul, specifically modernizing approval pathways for novel rare disease therapeutics to accelerate patient access in the UK.
Source: RAPS
Source: GlobeNewswire via Yahoo Finance | 3 November 2025
An overview of evolving global drug safety and pharmacovigilance regulatory requirements across major pharmaceutical markets, including the UK, European Union, and the United States.
Source: GlobeNewswire via Yahoo Finance
Source: MHRA | 6 November 2025
The UK's MHRA has granted approval for a new diagnostic tool, the Siiltibcy test, significantly improving the detection and diagnosis of Mycobacterium tuberculosis infection.
Source: MHRA
Corporate Newsroom Releases
Official press releases and direct communication from pharmaceutical companies focused on corporate strategy and innovation.
Company Press Releases
Source: GSK | 7 November 2025
GSK unveils comprehensive new clinical data from its advancing liver disease pipeline, focusing on chronic Hepatitis B (HBV) and treatments for Metabolic Dysfunction-associated Steatohepatitis (MASH) at AASLD 2025.
Source: GSK
Source: Pfizer / MarketScreener | 4 November 2025
Pfizer releases robust third-quarter 2025 financial results, leading the company to raise its full-year Earnings Per Share (EPS) guidance, signaling strong revenue performance.
Source: Pfizer / MarketScreener
Source: AstraZeneca | 5 November 2025
AstraZeneca announces the strategic acquisition of a specialized, early-stage oncology research platform to significantly expand its core cancer treatment development pipeline.
Source: AstraZeneca
Clinical Trials & R&D Milestones
Source: Yahoo Finance | 3 November 2025
Virax Biolabs successfully concludes patient recruitment in the UK for the ViraxImmune clinical study, an important immune-profiling trial phase.
Source: Yahoo Finance
Source: BioSpace | 5 November 2025
LIfT BioSciences is scheduled to present compelling preclinical data on its novel, first-in-class Alpha Neutrophil immunomodulatory platform for the treatment of solid tumours.
Source: BioSpace
Source: GSK | 7 November 2025
GSK reports updated clinical efficacy signals from its late-stage development assets targeting Chronic Hepatitis B (HBV) and Metabolic Dysfunction-associated Steatohepatitis (MASH).
Source: GSK
Financial & Executive News
Source: GeneOnline | 3 November 2025
Pfizer increases its projected 2025 profit guidance, a move coinciding with intensified Merger & Acquisition (M&A) activity across the global pharmaceutical industry.
Source: GeneOnline
Source: Financial Times | 6 November 2025
AstraZeneca’s Chief Executive provides strong commentary arguing that substantial drug pricing policy reforms are essential to protect the UK's global competitive standing in life sciences.
Source: Financial Times
Product & Approval Updates
Source: GlobeNewswire via Yahoo | 6 November 2025
Alvotech and Advanz Pharma secure UK marketing authorization for Gobivaz®, a new golimumab biosimilar, expanding therapeutic options for inflammatory conditions.
Source: GlobeNewswire via Yahoo
Source: BusinessWire | 5 November 2025
NICE has issued a recommendation supporting the reimbursement of delgocitinib, significantly expanding patient access to this treatment across England and Wales through updated pricing agreements.
Source: BusinessWire
Source: MHRA | 6 November 2025
The UK regulatory body, MHRA, grants national approval for the Siiltibcy test, marking a crucial new diagnostic aid for detecting both latent and active Mycobacterium tuberculosis infection.
Source: MHRA
GIC Pharma Feed
The latest developments, from trade analysis to corporate breakthroughs in the pharmaceutical industry.
Click a category below to access our curated weekly compilation of critical news.
• Trade & Professional Publications
• Association Updates
• Market Analysis & Commentary
• Regulatory & Compliance Watch
• Company Press Releases
• Clinical Trials & R&D Milestones
• Financial & Executive News
• Product & Approval Updates